Phreesia Past Earnings Performance
Past criteria checks 0/6
Phreesia's earnings have been declining at an average annual rate of -18%, while the Healthcare Services industry saw earnings growing at 6.8% annually. Revenues have been growing at an average rate of 26% per year.
Key information
-18.0%
Earnings growth rate
44.7%
EPS growth rate
Healthcare Services Industry Growth | 7.9% |
Revenue growth rate | 26.0% |
Return on equity | -39.9% |
Net Margin | -25.7% |
Next Earnings Update | 09 Dec 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Phreesia makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Jul 24 | 390 | -100 | 207 | 117 |
30 Apr 24 | 374 | -119 | 216 | 115 |
31 Jan 24 | 356 | -137 | 222 | 112 |
31 Oct 23 | 338 | -144 | 228 | 108 |
31 Jul 23 | 319 | -152 | 228 | 102 |
30 Apr 23 | 301 | -162 | 228 | 97 |
31 Jan 23 | 281 | -176 | 232 | 91 |
31 Oct 22 | 262 | -185 | 234 | 83 |
31 Jul 22 | 245 | -181 | 228 | 76 |
30 Apr 22 | 228 | -158 | 208 | 65 |
31 Jan 22 | 213 | -118 | 174 | 52 |
31 Oct 21 | 197 | -80 | 140 | 41 |
31 Jul 21 | 180 | -50 | 111 | 32 |
30 Apr 21 | 164 | -32 | 93 | 26 |
31 Jan 21 | 149 | -27 | 83 | 23 |
31 Oct 20 | 140 | -23 | 77 | 21 |
31 Jul 20 | 134 | -19 | 71 | 20 |
30 Apr 20 | 130 | -83 | 67 | 19 |
31 Jan 20 | 125 | -91 | 63 | 19 |
31 Oct 19 | 118 | -102 | 57 | 18 |
31 Jul 19 | 110 | -113 | 54 | 17 |
30 Apr 19 | 104 | -54 | 49 | 16 |
31 Jan 19 | 100 | -45 | 46 | 14 |
31 Jan 18 | 80 | -38 | 44 | 11 |
Quality Earnings: 19P is currently unprofitable.
Growing Profit Margin: 19P is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 19P is unprofitable, and losses have increased over the past 5 years at a rate of 18% per year.
Accelerating Growth: Unable to compare 19P's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 19P is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (3.6%).
Return on Equity
High ROE: 19P has a negative Return on Equity (-39.92%), as it is currently unprofitable.